PubRank

Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT (GIFT)

Clinical Trial ID NCT01006733

PubWeight™ 23.58‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01006733

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther 2011 4.42
2 Integration of genetic, clinical, and INR data to refine warfarin dosing. Clin Pharmacol Ther 2010 2.21
3 Genetic warfarin dosing: tables versus algorithms. J Am Coll Cardiol 2011 1.43
4 Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial. JAMA 2017 1.39
5 Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design. Pharmacogenomics J 2011 1.38
6 Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy. Thromb Haemost 2011 1.35
7 Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy. J Thromb Haemost 2009 1.22
8 Role of pharmacogenomics in the management of traditional and novel oral anticoagulants. Pharmacotherapy 2011 1.16
9 Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 2012 1.09
10 Gamma-glutamyl carboxylase and its influence on warfarin dose. Thromb Haemost 2010 1.02
11 Clinically relevant genetic variations in drug metabolizing enzymes. Curr Drug Metab 2011 0.99
12 Genotype and risk of major bleeding during warfarin treatment. Pharmacogenomics 2014 0.88
13 Pharmacogenetic testing: Current Evidence of Clinical Utility. Ther Adv Drug Saf 2013 0.87
14 Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation. Pharmacogenomics 2012 0.83
15 Genotype-guided drug prescribing: a systematic review and meta-analysis of randomized control trials. Br J Clin Pharmacol 2015 0.82
16 The Creating an Optimal Warfarin Nomogram (CROWN) Study. Thromb Haemost 2011 0.82
17 Warfarin pharmacogenetics: challenges and opportunities for clinical translation. Front Pharmacol 2012 0.81
18 Myocardial ischaemia after hip and knee arthroplasty: incidence and risk factors. Int Orthop 2015 0.80
19 Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics. Pharmgenomics Pers Med 2015 0.79
20 Pharmacogenetic association study of warfarin safety endpoints in Puerto Ricans. P R Health Sci J 2014 0.76
21 Clopidogrel and warfarin pharmacogenetic tests: what is the evidence for use in clinical practice? Curr Opin Cardiol 2013 0.75
22 Anticoagulant therapy: warfarin sensitivity genotyping closer to clinical practice. Nat Rev Cardiol 2010 0.75
23 Use of signals and systems engineering to improve the safety of warfarin initiation. J Thromb Thrombolysis 2016 0.75
Next 100